AU508262B2 - Imidazoles - Google Patents

Imidazoles

Info

Publication number
AU508262B2
AU508262B2 AU16447/76A AU1644776A AU508262B2 AU 508262 B2 AU508262 B2 AU 508262B2 AU 16447/76 A AU16447/76 A AU 16447/76A AU 1644776 A AU1644776 A AU 1644776A AU 508262 B2 AU508262 B2 AU 508262B2
Authority
AU
Australia
Prior art keywords
imidazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU16447/76A
Other languages
English (en)
Other versions
AU1644776A (en
Inventor
G R White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of AU1644776A publication Critical patent/AU1644776A/en
Application granted granted Critical
Publication of AU508262B2 publication Critical patent/AU508262B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU16447/76A 1975-07-31 1976-07-30 Imidazoles Expired AU508262B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB31968/75 1975-07-31
GB31968/75A GB1565647A (en) 1975-07-31 1975-07-31 Pharmacologically active compounds 4-substituted-imidazole-5-methanols

Publications (2)

Publication Number Publication Date
AU1644776A AU1644776A (en) 1978-02-02
AU508262B2 true AU508262B2 (en) 1980-03-13

Family

ID=10331071

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16447/76A Expired AU508262B2 (en) 1975-07-31 1976-07-30 Imidazoles

Country Status (28)

Country Link
JP (1) JPS5219663A (zh)
AR (1) AR213100A1 (zh)
AT (1) AT356668B (zh)
AU (1) AU508262B2 (zh)
BE (1) BE843840A (zh)
CA (1) CA1075702A (zh)
CS (1) CS203054B2 (zh)
DD (1) DD125205A5 (zh)
DE (1) DE2634430A1 (zh)
DK (1) DK316376A (zh)
ES (1) ES450309A1 (zh)
FI (1) FI762191A (zh)
FR (1) FR2319341A1 (zh)
GB (1) GB1565647A (zh)
GR (1) GR61114B (zh)
HU (1) HU174068B (zh)
IL (1) IL50006A0 (zh)
LU (1) LU75495A1 (zh)
NL (1) NL7608505A (zh)
NO (1) NO762659L (zh)
OA (1) OA05405A (zh)
PH (1) PH13417A (zh)
PT (1) PT65377B (zh)
RO (1) RO72312B (zh)
SE (1) SE7608478L (zh)
SU (1) SU655310A3 (zh)
ZA (1) ZA763686B (zh)
ZM (1) ZM9676A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
USRE31588E (en) * 1977-06-03 1984-05-22 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
US4112234A (en) 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
US4233302A (en) 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
EP0008596A1 (fr) * 1978-09-04 1980-03-19 DEVINTER Europe S.A. Société anonyme dite: Procédé de préparation de dérivés du type 4-hydroxyméthyl imidazole à partir d'esters d'acides 4-imidazole carboxyliques correspondants
US4200760A (en) * 1978-09-26 1980-04-29 Bristol-Myers Company Imidazolylalkylthioalkylamino-ethylene derivatives
JPS5914460B2 (ja) * 1978-12-27 1984-04-04 相互薬工株式会社 Ｈ↓２受容体「きつ」抗剤シメチジンの製造法
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA938556A (en) * 1970-06-25 1973-12-18 Smith Kline And French Laboratories Limited Pharmaceutical compositions containing thiourea derivatives

Also Published As

Publication number Publication date
GR61114B (en) 1978-09-13
ATA552376A (de) 1979-10-15
AU1644776A (en) 1978-02-02
CA1075702A (en) 1980-04-15
RO72312A (ro) 1984-03-15
FR2319341B1 (zh) 1979-01-12
FR2319341A1 (fr) 1977-02-25
SU655310A3 (ru) 1979-03-30
PT65377A (en) 1976-08-01
JPS5219663A (en) 1977-02-15
PH13417A (en) 1980-03-30
AT356668B (de) 1980-05-12
ZA763686B (en) 1977-05-25
BE843840A (fr) 1977-01-06
NO762659L (zh) 1977-02-01
SE7608478L (sv) 1977-02-01
AR213100A1 (es) 1978-12-15
IL50006A0 (en) 1976-09-30
NL7608505A (nl) 1977-02-02
DK316376A (da) 1977-02-01
GB1565647A (en) 1980-04-23
LU75495A1 (zh) 1977-03-03
FI762191A (zh) 1977-02-01
CS203054B2 (en) 1981-02-27
OA05405A (fr) 1981-02-28
HU174068B (hu) 1979-10-28
DD125205A5 (zh) 1977-04-06
ES450309A1 (es) 1977-12-01
RO72312B (ro) 1984-03-31
PT65377B (en) 1978-01-19
DE2634430A1 (de) 1977-02-10
ZM9676A1 (en) 1977-07-21

Similar Documents

Publication Publication Date Title
AU502679B2 (en) Imidazoles
AU1108376A (en) Polyhemoglobin
AU1006976A (en) Inhilator
AU1025376A (en) Pourer-stopper
AU1230276A (en) Amidinoureas
AU1230176A (en) Imidinoureas
AU1441776A (en) Thieno-pyridines
AU508259B2 (en) Bottlecap
MY8100323A (en) Imidazoles
AU504085B2 (en) Imidazole derivatves
AU503981B2 (en) Imidazoles
AU1128976A (en) Magneto-alternator
AU1417076A (en) Propargyl-2 phenylamino-2-impazolines
AU508262B2 (en) Imidazoles
AU501151B2 (en) Silacyclo pentenyl-bis-epsilon-caprolactam
AU504009B2 (en) Imidazole derivatives
AU1520376A (en) Benzocycloheptathiophens
AU1408076A (en) Lysolipin Antibioties
KE3118A (en) Imidazoles
AU1191776A (en) Fluoro-prostaglandins
AU1393076A (en) Dihydromocimycin
AU514986B2 (en) Imidazole derivatives
AU1398876A (en) Aryl-di-thioureas
AU4892279A (en) Dentrifrices
AU1492376A (en) Alpha-pyrones